HSA Product

RIFAREN 300 CAPSULE 300 mg

Product approved by Health Sciences Authority (SG)

Basic Information

Product Name

RIFAREN 300 CAPSULE 300 mg

Dosage Form

CAPSULE

Regulatory Information

Approval Number

SIN10052P

Approval Date

September 13, 1998

Forensic Classification

Prescription Only

Drug Type

Therapeutic

Route of Administration

ORAL

Record Created

August 10, 2023

Last Updated

June 3, 2025

ATC Business ID

XJ04AB02

Company Information

ManufacturerREMEDICA LTD

Registrant

GOLDPLUS UNIVERSAL PTE LTD

Active Ingredients

Strength: 300 mg

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy